期刊文献+

980nm半导体激光剥橘式切除术治疗大体积前列腺增生症60例效果分析 被引量:2

The resection of prostate-tangerine technique with 980 nm diode laser in 60 patients of high volum benign prostatic hyperplasia
原文传递
导出
摘要 目的研究使用980nm半导体红激光剥橘式切除术治疗大体积前列腺增生(BPH)的安全性和疗效。方法应用980nm半导体红激光对60例BPH患者行剥橘式切除术。患者年龄65~89岁,平均前列腺体积为74.5±13ml,观察并记录手术时间、术中出血量,记录并统计分析手术前后国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)及剩余尿量(PVR)等指标的变化情况。结果所有患者均由同一术者完成手术并全部成功,手术时间平均70.2±16.9min,术中无明显出血,无输血病例。患者术后留置尿管2~5d,平均留置尿管时间2.4±0.3d。术后1—3月随访IPSS明显低于术前(P=0.000),Qmax及PVR明显好于术前(P=0.000)。结论980nm半导体红激光剥橘式切除术治疗大体积良性前列腺增生症是安全有效的。 Objective To explore the efficacy and safety of the resection of prostate-tangerine technique with 980 nm diode laser benign prostatic chyperplasia (BPH) . Methods Data of 60 patients with high vloum BPH treated with the resection of prostate-tangerine technique with 980 nm diode laser were reviewed. The age of the patients were 65-89 years old, and mean prostate volume was 74. 5_± 13 ml. The mean operative time, blood loss were oberseved and recored, the international prostate symptom score(IPSS) , quality of life score (QOL) , maximum urinary flow rate(Qmax) and residual urine volume (PVR) were collected and analyzed. Results The 60 cases were safe during the perioperative period. The average operation time was (70. 2± 16. 9) min, and there was no obvious bleeding during the operation and no blood transfusion cases. The time of remove the transurethral catheter was 2-5 d,and the mean time was (2.4_±0. 3) d. Follow up 1-3 months after operation,a significant reduction in IPPS was reported ( P = 0. 000) , significant durable improvements in Qmax, PVR before operation(P= 0. 000) . Conclusion Transurethral vaporization of 980 nm diode laser could be a safe and effective treatment modality for BPH.
出处 《中国综合临床》 2016年第4期362-364,共3页 Clinical Medicine of China
关键词 前列腺增生 剥橘式切除术 激光治疗 Benign Prostatic hyperplasia The resection of prostate-tangerine technique Lasertherapy
  • 相关文献

二级参考文献9

  • 1Gilling P J, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 1995; 9: 151-3.
  • 2Gilling P J, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996; 10: 459-61.
  • 3Fried NM. Potential applications of the erbium:YAG laser in endourology. J Endourol 2001; 15: 889-94.
  • 4Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94μm. J Endourol 2005; 19: 25-31.
  • 5Fried NM. High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 μm. Lasers Surg Med 2005; 36: 52-6.
  • 6Xia S J, Zhuo J, Sun XW, Han BM, Shao Y, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53: 382-9.
  • 7Gilling P. Holmium laser enucleation of the prostate (HoLEP). BJU Int 2008; 101: 131-42.
  • 8Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 2007; 25: 257-62.
  • 9Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 2008; 22: 1041-5.

共引文献71

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部